Article Text

Download PDFPDF
141 Cognitive processing speed predicts disease progression in SPMS: post hoc analysis from the EXPAND study
  1. Iris-Katharina Penner1,2,
  2. Gavin Giovannoni3,
  3. Tanuja Chitnis4,
  4. Patrick Vermesch5,
  5. Sophie Arnould6,
  6. Virginia DeLasHeras6,
  7. Goeril Karlsson6,
  8. Daniela Piani-Meier6,
  9. Ludwig Kappos7,8,
  10. Ralph Benedict9
  1. 1Department of Neurology, Heinrich Heine University, Germany
  2. 2Center for Applied Neurocognition and Neuropsychological Research, Düsseldorf, Germany
  3. 3Blizard Institute, Barts and The London School of Medicine and Dentistry
  4. 4Department of Neurology, Brigham and Women’s Hospital, Boston, MA, USA
  5. 5University Lille, INSERM, Lille, France
  6. 6Novartis Pharma, Switzerland
  7. 7Research Center for Clinical Neuroimmunology and Neuroscience Basel
  8. 8Neurologic Clinic and Policlinic, Department of Head, Spine and Neuromedicine, University Hospital
  9. 9Department of Neurology, University at Buffalo, Buffalo, NY, USA

Abstract

Objective Assess the predictive value of cognitive processing speed (CPS), using the Symbol Digit Modali- ties Test (SDMT) score, on disability progression in secondary progressive multiple sclerosis (SPMS).

Design/Methods SPMS patients from the Phase 3 EXPAND study (core part [CP] and core+extension part [CP+EP]) were categorised into quartiles of baseline SDMT score (worst-WQ [Q1], intermediate [Q2-Q3], and best-BQ [Q4] quartile). The predictive value of baseline SDMT quartiles for time-to-wheelchair (T2W; i.e., Expanded Disability Status Scale [EDSS] score ≥7) sustained until end of follow-up, or 6-month confirmed disability progression (6mCDP) by EDSS, were assessed at the end of the CP (up to 37-months) and CP+EP (up to 5-years) by Cox regression (adjusted for treatment, age, gender, baseline EDSS, baseline SDMT quartile, and treatment-by-baseline SDMT quartile interaction).

Results Analyses included 1628/1651 patients (98.6%) randomised in EXPAND (baseline SDMT: WQ, n=435; intermediate, n=808; BQ, n=385). Risk of T2W (WQ vs BQ) was higher in the CP (HRWQ/BQ=1.31, 95% CI:0.72–2.38; p=0.37) and increased with long-term follow-up (HRWQ/BQ=1.81; 1.17–2.78; p=0.01). Baseline SDMT was not predictive of 6mCDP. The predictive value of on-study SDMT score change will be presented.

Conclusions The results support the predictive value of CPS for long-term physical disability progression in SPMS. Funding: Novartis Pharma AG, Basel, Switzerland.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.